Skip to main content

Table 1 Baseline characteristics of subjects in 1st, 2nd and validation cohort

From: Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX)

  1st Screening 2nd Screening Validation   
  Patients (n = 10) Patients (n = 134) HD (n = 24) Patients (n = 70) HD (n = 42)
Age 72.4 (3.53) 68.1 (10.4) 64.4 (8.03) 68.6 (10.3) 53.0 (4.57)
Male gender 9 (90) 106 (79.3) 21 (87.5) 54 (77.1) 25 (59.5)
Hypertension 6 (60) 88 (65.9) 1 (4.17) 45 (64.3) N/A
Diabetes 3 (30) 35 (25.9) 3 (12.5) 17 (24.3) N/A
Hyperlipidemia 3 (30) 36 (26.7) 1 (4.17) 22 (31.4) N/A
Smoking 1 (10) 46 (34.1) 6 (25.0) 24 (34.3) N/A
Stroke 10 (100) 129 (96.3) 0 (0) 67 (95.7) 0
Stroke etiology    -   -
LAA 10 (100) 34 (21.5)   29 (41.4)  
SVD 0 (0) 62 (39.2)   18 (25.7)4  
CE 0 (0) 14 (8.9)   (5.71)  
UD and others 0 (0) 24 (15.2)   16 (23.9)  
Carotid stenosis >50% 10 (100) 31/102 (30.4) N/A 38/60 (63.3) N/A
  1. Baseline characteristics of subjects in 1st, 2nd and validation cohort are displayed. Data represents means (SD) for numerical data and n (%) for categorical data. CE, cardioembolism. HD, healthy donor. N/A, not assessed. LAA, large artery atherosclerosis. SVD, small vessel disease. UD, undetermined ethiology.